Back to Search
Start Over
Evaluation of smartphone oral contraceptive reminder applications.
- Source :
-
Research in social & administrative pharmacy : RSAP [Res Social Adm Pharm] 2015 Jul-Aug; Vol. 11 (4), pp. 584-7. Date of Electronic Publication: 2014 Dec 16. - Publication Year :
- 2015
-
Abstract
- Background: Oral contraceptives (OCs) are the most widely used contraceptive method among women of reproductive age in the United States (US). Routine download and use of health-related smartphone applications (apps) continues to increase.<br />Objective: The purpose of this study was to evaluate the utility of English-language, smartphone-platform OC reminder apps currently available for download in the US.<br />Methods: During June-July 2013, official Internet-based, mobile app platforms for the two major smartphone operating systems in the US-Android (Google Play Store) and iPhone (iTunes)-were searched. "Birth control," "the pill," and "contraception" were entered into the search-bar of each Smartphone store. Apps were assessed for the following: cost, health care professionals' involvement in app development, reminder mechanisms, and functionality.<br />Results: Of the 39 unique OC reminder apps meeting inclusion criteria, 7 (18%) did not operate as intended when downloaded. Most apps functioned without an Internet connection (97%) and included pop-up notifications (84%).<br />Conclusions: Certain app features overcome common causes of missing an alarm, and hypothetically, may minimize likelihood of an OC user missing a daily pill. Health care providers should inform users of potential pitfalls and advise them that an OC reminder app should be not be used as a sole reminder method.<br /> (Copyright © 2015 Elsevier Inc. All rights reserved.)
Details
- Language :
- English
- ISSN :
- 1934-8150
- Volume :
- 11
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Research in social & administrative pharmacy : RSAP
- Publication Type :
- Academic Journal
- Accession number :
- 25640888
- Full Text :
- https://doi.org/10.1016/j.sapharm.2014.11.001